Regeneron Pharmaceuticals (REGN) News Headlines

▮ More

Date

Headline

7/3/2020 1:45:46 AM Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals

7/3/2020 1:04:30 AM IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch

6/24/2020 3:39:51 PM Regeneron To Defend Allegations On Contributions To Patient Assistance Charity

6/24/2020 3:29:21 PM Regeneron To Defend Allegations Related To Contributions To Patient Assistance Charity In 2013 And Early 2014

6/24/2020 2:02:44 PM REGN:Data Shows Potential To Enhance Cancer Treatment By Combining Novel CostimulatoryBispecific Antibodies With Libtayo

6/23/2020 9:00:42 AM Regeneron To Present At BMO Prescriptions For Success Healthcare Conference; Webcast At 10:00 AM ET

6/19/2020 7:46:24 AM Regeneron : China Okays Dupixent To Treat Moderate-to-Severe Atopic Dermatitis In Adults

6/19/2020 7:33:39 AM Regeneron And Sanofi: NMPA In China Approves Dupixent For Moderate-to-severe Atopic Dermatitis In Adults

6/11/2020 7:29:14 AM Regeneron Begins Clinical Trial Of Anti-Viral Antibody Cocktail Against COVID-19

6/11/2020 7:21:13 AM Regeneron Says Two Science Publications Highlight Potential Of REGN-COV2 Anti-Viral Antibody Cocktail

6/11/2020 7:02:44 AM Regeneron's (REGN) Resplendent Journey From $60 To $600 In 9 Years

6/11/2020 7:02:23 AM Regeneron Begins First Clinical Trial Of REGN-COV2, Its Investigational Dual Antibody Cocktail For COVID-19

6/11/2020 1:14:42 AM Sanofi To Present Strategy For Dupixent In Type 2 Inflammatory Diseases

6/11/2020 1:01:42 AM Regeneron Announces Updates Related To Dupixent Collaboration Programs With Sanofi

6/9/2020 2:00:05 PM Regeneron Pharma To Present At Goldman Sachs Global Healthcare Conference; Webcast At 3:00 PM ET

6/2/2020 12:27:39 AM NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps

6/1/2020 7:14:50 AM Regeneron Expands Existing Collaboration With Intellia - Quick Facts

6/1/2020 7:02:19 AM Regeneron And Intellia To Co-develop Potential Hemophilia A And B Treatments

5/29/2020 8:28:08 AM Regeneron : Data On Libtayo Shows Longer Durability, Higher Complete Response Rates In Skin Cancer

5/29/2020 8:03:53 AM Regeneron Pharma And Sanofi Announce Longer-term Data From Pivotal Phase 2 Trial For PD-1 Inhibitor Libtayo